Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm
Korean J Hepatol. 2009;15(4):474-485. Published online 2009 Dec 31 DOI: https://doi.org/10.3350/kjhep.2009.15.4.474
Citations to this article as recorded by 
Prognostic value of aspartate aminotransferase/alanine aminotransferase ratio in hepatocellular carcinoma after hepatectomy
Rong-Rui Huo, Li-Xin Pan, Pei-Sheng Wu, Xiu-Mei Liang, Xue-Mei You, Liang Ma, Jian-Hong Zhong
BJS Open.2024;[Epub] CrossRef
Clinical feasibility and efficacy of stereotactic body radiotherapy for hepatocellular carcinoma: A systematic review and meta-analysis of observational studies
Chai Hong Rim, Hyun Ju Kim, Jinsil Seong
Radiotherapy and Oncology.2019; 131: 135. CrossRef
Efficacy and safety of radiofrequency ablation and transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: A meta‐analysis
Yulan Wang, Tianxing Deng, Li Zeng, Weiqing Chen
Hepatology Research.2016; 46(1): 58. CrossRef
Transarterial Chemoembolization vs. Radiofrequency Ablation for the Treatment of Single Hepatocellular Carcinoma 2 cm or Smaller
Jong Woo Kim, Jin Hyoung Kim, Kyu-Bo Sung, Heung-Kyu Ko, Ji Hoon Shin, Pyo Nyun Kim, Hyun-Kyung Choi, Gi-Young Ko, Hyun-Ki Yoon, Seng-Yong Chun, Dong Il Gwon
American Journal of Gastroenterology.2014; 109(8): 1234. CrossRef